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NC-ND license (http://creativecommoSummary Background: Allied disorders of Hirschsprung’s disease (ADHD) have been proposed
to be the concept of the functional obstruction of the intestine with the presence of ganglion
cells in the terminal rectum. They are classified into two categories based on pathology: (1)
abnormal ganglia, including immaturity of ganglia, hypoganglionosis (HG), and intestinal
neuronal dysplasia; (2) normal ganglia, including megacystis microcolon intestinal hypoperis-
talsis syndrome (MMIHS), segmental dilatation (SD), internal anal sphincter achalasia (IASA),
and chronic idiopathic intestinal pseudo-obstruction (CIIP). Some of these show poor prognosis,
therefore, the establishment of criteria and appropriate treatment strategies is required.
Methods: The questionnaires were sent to the 161 major institutes of pediatric surgery or
gastroenterology in Japan, in order to collect the cases of ADHD during 10 years from 2001
and 2010.
Results: In total, 355 cases were collected. They included 28 immaturity of ganglia, 130 HG
(121 congenital, 9 acquired), 18 intestinal neuronal dysplasia, 33 MMIHS, 43 SD, three IASA,
and 100 CIIP. Of the 95 institutes, 69 (72.6%) had their own criteria for ADHD. Criteria were
based on clinical symptoms and signs, and conventional pathological examinations. Prognosis
was poor in congenital HG, MMIHS, and CIIP, while the others showed good survival rates.
Conclusion: Almost all Japanese cases of ADHD in the past 10 years were collected. Congenital
HG and CIIP showed relatively high incidence, whereas acquired HG and IASA were extremelys declare that they have no financial or nonfinancial conflicts of interest related to the subject matter
ipt.
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30 T. Taguchi et al.rare in Japan. The criteria of each disorder were also collected and summarized. Prognosis was
poor in congenital HG, MMIHS, and CIIP.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Table 1 Hirschsprung’s disease and allied disorders
(Ehrenpreis 1966).3
With abnormalities of ganglion cells
Hirschsprung’s disease
Congenital megacolon
Congenital aganglionosis
Chagas’ disease
Acquired megacolon
Aperistalsis
Hypoganglionossis
Immaturity of ganglion cells
Without abnormalities of ganglion cells
Aetiology obscure
Idiopathic megacolon
Functional megacolon
Psychogenic megacolon
Megarectum
Chronic constipation
Pseudo-hirschsprung1. Introduction
Allied disorders of Hirschsprung’s disease (ADHD) have been
understood as the conditions that clinically resemble
Hirschsprung’s disease (HD), despite the presence of gan-
glion cells in the terminal rectum.1 Patients with Hirsch-
sprung’s disease generally present in the newborn period
with delayed passage of meconium and abdominal disten-
tion or as a young child with severe chronic constipation.
Patients with ADHD show similar symptoms and signs to HD,
but they can be distinguished from HD by the pathological
findings. The term pseudo HD was proposed by Ravitch in
1958.2 They encountered patients referred for treatment of
megacolon in whom the difficulty lay elsewhere rather than
in the congenital absence of ganglion cells of the myenteric
plexuses of a segment of the rectum or of the colon and
rectum. Bentley et al3 summarized HD and allied disorders
in the Seminar on Pseudo-Hirschsprung’s Disease and
Related Disorders. The main thing to remember was that
the various disease patterns were essentially determined
by their underlying pathology, irrespective of what we
choose to call them. ADHD was classified into two cate-
gories based on histology3: those with abnormality of gan-
glion cells and those without abnormality of ganglion cells
(Table 1). Puri and Gosemann4 called this group variants of
HD, including four disorders: intestinal neuronal dysplasia
(IND); isolated hypoganglionosis (HG); internal anal
sphincter achalasia (IASA); and megacystis microcolon in-
testinal hypoperistalsis syndrome (MMIHS) in 2012.4 They
did not treat chronic idiopathic intestinal pseudo-
obstruction (CIIP) as one of the variants of HD.
Okamoto and Toyosaka5 used the term of pseudo-
Hirschsprung’s disease in the Japanese literature. It was
defined as a congenital, nonmechanical obstruction of the
intestine with presence of intramural ganglion cells in the
terminal rectum. They classified them based on histology
into two categories for six disorders: immaturity of ganglia
(IG); HG; hypogenesis; IND; CIIP; and MMIHS.5
According to the literature and Okamoto and Toyosaka’s5
classification, ADHD was classified into two categories
depending on thepathological findings (Table 2): (1) abnormal
ganglia, including IG, HG, and IND; (2) normal ganglia,
including MMIHS, segmental dilatation (SD), IASA, and CIIP.
Some of them show poor prognosis; therefore, establishment
of criteria, severity, and treatment strategy are required. In
order to examine the incidence and criteria of ADHD, a pre-
liminary nationwide survey was planned in Japan.Segmental dilatation of the colon
Achalasia of distal rectal segment
Clear etiology
Symptomatic megacolon
Secondary megacolon (anal stricture,
myxoedema, cerebral atrophy)2. Patients and methods
As a nationwide retrospective cohort study, supported by
Ministry of Health and Welfare, Japan, the preliminary
questionnaires, requesting the number of cases of ADHDfrom January 2000 to December 2009 and the criteria of
each institute, were sent to the 161 major institutes of
pediatric surgery or pediatric gastroenterology represent-
ing the core members of the Japanese Society of Pediatric
Surgeons, the Japanese Society of Pediatric Nutrition,
Gastroenterology, and Hepatology, and the Japanese Study
Group of Pediatric Constipation. Therefore almost all in-
stitutes that are treating ADHD are considered covered. The
number of patients, including the definite and suspected
cases, based on the classification of ADHD in Japan (Table
1) and the survival rate and clinical outcome were asked.
The criteria of each institute were asked to be answered as
free descriptions. The criteria for definitive or suspected
were dependent on each institute.
This study was performed according to the Ethical
Guidelines for Clinical Research published by the Ministry of
Health, Labor, and Welfare of Japan on July 30, 2003. And
this study was approved by the Ethical Committee for
Clinical Research of Kyushu University Hospital, Fukuoka,
Japan (No. 24-163).
3. Results
Replies were obtained from 157 of 161 institutes (98%). Out
of 157 institutes, 95 (61%) had ADHD. In totally, 355 cases,
Table 2 Classification for allied disorders of Hirsch-
sprung’s disease in Japanese survey.
(1) Abnormal ganglia (abnormal histology in hematoxyline
eosin or acetylcholinesterase staining)
Immaturity of ganglia (or immature ganglionosis)
Hypoganglionosis (or oligoganglionosis)
Congenital hypoganglionosis
(or hypogenesis, hypoplasia)
Acquired hypoganglionosis intestinal
neuronal dysplasia
(2) Normal ganglia (normal histology in hematoxyline
eosin or acetylcholinesterase staining)
Megacystis microcolon intestinal
hypoperistalsis syndrome
Segmental dilatation of intestine
Internal anal sphincter achalasia
Chronic idiopathic intestinal pseudo-obstruction
Table 3 Numbers of patients in each disorder.
Definitive Suspected Total Okamoto
and
Toyosaka2
Abnormal
ganglia
IG 22 6 28 (7.9) 26 (24.1)
HG 112 18 30 (36.6) 44 (40.8)
Allied disorders of Hirschsprung’s disease 31including 287 definite cases and 68 suspected cases were
collected between 2001 and 2010. More than half of the
institutes (53 institutes) had three cases or fewer
(Figure 1). The mean number of cases per institute was 3.7
cases. There were 165 of 355 cases (47%) treated in uni-
versity hospitals, 93 (26%) in children’s hospitals, and 97
(27%) in general hospitals. ADHD included 28 IG, 130 HG
(121 congenital, 9 acquired), and 18 IND in abnormal
ganglia; and 33 MMIHS, 42 SD, three IASA, and 100 CIIP in
normal ganglia, and these numbers were compared with
those of the previous study in Japan (Table 3).2
Of the 95 institutes who experienced ADHD, 69 (73%) had
their own criteria. The percentages of institutes that had
criteria for each disorder were between 28% and 83% (Table
4). More than 80% of institutes had criteria for congenital
HG and CIIP, while only  30% institutes had criteria for
acquired HG and IASA. Criteria of each disorder were based
on clinical symptoms and signs, examinations including
radiography findings, manometric study, and conventional
pathological examinations including hematoxylineeosin
(HE; Figure 2) and acetylchoinesterase (AchE). According to
answers of the questionnaires, the major criteria listed in
each disorder are follows. IG: small ganglion cells, 37/46
(80%); number and distribution of ganglion cells are normal,
19/46 (41%); chronological improvement of clinical symp-
toms, 8/46 (17%); intestinal obstruction on neonatal onset,Figure 1 Number of cases in each institute.6/46 (13%); normal AchE staining, 3/46 (7%); abdominal
distention, 2/46 (4%); and microcolon, 2/46 (4%). Congen-
ital HG: few ganglion cells, 41/55 (75%); few small ganglion
cells, 14/55 (25%); intestinal obstruction on neonatal onset,
11/55 (20%); hypoplasia of plexus, 4/55 (7%); normal AchE
staining, 4/55 (7%); negative rectospincteric reflex, 4/55
(7%); and delayed meconium pass, 2/55 (4%). Acquired HG:
ganglion cells decrease in number after some time, 6/19
(32%); few ganglion cells, 4/19 (21%); normal at birth and
symptoms occur after some time, 2/19 (11%); no congenital
factors, 2/19 (11%); chronic constipation and persistent
bowel dilatation, 2/19 (11%); and normal AchE staining 1
(5%). IND: increased AchE positive fibers in the lamina
propria, 17/34 (50%); ectopic ganglion cells, 14/34 (41%);
giant ganglia (> 5 ganglion cells per plexus), 13/34 (38%);
severe constipation or rectal dysmotility, 9/34 (26%);
hyperganglionosis, 6/34 (18%); and dilatation of bowel, 2/
34 (6%). MMIHS: megacystis, 39/47 (83%); permanent severe
symptoms of intestinal obstruction, 35/47 (74%); micro-
colon 27/47 (57%); normal histology of intestinal neurons
and muscles, 25/47 (53%); neonatal onset, 16/47 (34%);
normal AchE staining, 5/47 (11%); and positive rectospinc-
teric reflex 4/47 (9%). SD: persistent segmental dilatation,
36/42 (86%); normal histology of intestinal ganglion cells,
24/42 (57%); no mechanical obstruction distal to dilatation,
13/42 (31%); signs of intestinal obstruction in radiography,
7/42 (17%); complete curability after resection of dilated
bowel, 5/42 (12%); abrupt caliber change to the normal
intestine, 3/42 (7%); thick or thin muscle layer, 2/42 (5%);
and positive rectospincteric reflex, 2/42 (5%). IASA: nega-
tive rectospincteric reflex, 9/21 (43%); normal AchE stain-
ing, 9/21 (43%); severe constipation since birth, 7/21 (33%);
and absence of narrow segment, 4/21 (19%). CIIP: symp-
toms of intestinal obstruction without mechanical cause,
57/57 (100%); normal histology of intestinal ganglion cells,Congenital 104 17 121 (34.1)
Acquired 8 1 9 (2.5)
IND 8 10 18 (5.1) 5 (4.6)
Normal
ganglia
MMIHS 27 6 33 (9.3) 9 (8.3)
SD 33 10 43 (12.1) NE
IASA 1 2 3 (0.8) NE
CIIP 84 16 100 (28.2) 24 (22.2)
Total 287 68 355 (100) 108 (100)
CIIP Z chronic idiopathic intestinal pseudo-obstruction;
HG Z hypoganglionosis; IASA Z internal anal sphincter acha-
lasia; IG Z immaturity of ganglia; IND Z intestinal neuronal
dysplasia; MMIHS Z megacystis microcolon intestinal hypoper-
istalsis syndrome; NE Z not examined; SD Z segmental
dilatation.
Table 4 The percentages of institutes that had criteria
for each disorder.
Abnormal ganglia
IG 46/69 (67%)
HG
Congenital HG 55/69 (80%)
Acquired HG 19/69 (28%)
IND 34/69 (49%)
Normal ganglia
MMIHS 47/69 (68%)
SD 42/69 (61%)
IASA 21/69 (30%)
CIIP 57/69 (83%)
CIIP Z chronic idiopathic intestinal pseudo-obstruction;
HG Z hypoganglionosis; IASA Z internal anal sphincter acha-
lasia; IG Z immaturity of ganglia; IND Z intestinal neuronal
dysplasia; MMIHS Z megacystis microcolon intestinal hypoper-
istalsis syndrome; SD Z segmental dilatation.
32 T. Taguchi et al.46/57 (81%); abnormality of urinary tract, 13/57 (23%);
dilatation of intestine in radiography 9/57, (16%); positive
rectospincteric reflex, 8/57 (14%); intermittent or recur-
rent symptoms, 6/57 (11%); and normal AchE staining, 6/57
(11%). For the diagnosis of IG, immunohistochemical studies
using Bcl-2 antibody were performed and shown to be
effective in a few institutes (Figure 3).
The survival rates of each entity for which the follow-up
data were available are shown in Table 5. Three entities,
congenital HG, MMIHS, and CIIP, showed poor survival rate,(c) Congenital Hypoganglionosis
(a) Normal ganglia (CIIP, MMIHS)
Figure 2 Typical pathology of allied disorders of Hirschsprung’s di
(megacystis microcolon intestinal hypoperistalsis syndrome, MM
segmental dilatation). (B) Immaturity of ganglia. (C) Congenital hyp
hypoganglionosis. Arrows indicate degenerated ganglion cells.compared with those of the other five entities. These three
entities required long-term nutritional support, including
parenteral and enteral nutrition (Table 6). In particular,
outcome is extremely poor in MMIHS.4. Discussion
Almost all Japanese cases (w 98%) of ADHD in 10 years were
collected in this nationwide survey. However, the number
of cases in each institute was very small, and actually more
than half of the institutes (53 institutes) had three cases or
fewer. Therefore nation-wide survey is considered to be
important.
Okamoto and Toyosaka5 published a multicenter study of
ADHD in the Japanese literature in 1994. They classified
ADHD into two categories based on pathology: (1) abnormal
histology including IG, HG, hypogenesis, and IND; and (2)
normal histology, including CIIP6 and MMIHS. We followed
the classification of Okamoto and Toyosaka5 in order to
compare our results to those of their survey. In addition to
Okamoto and Toyosaka’s5 classification, SD and IASA are
included in this study, referring to the literature.1,3
The presence of immaturity and HG was confirmed and
published by Taguchi et al.7 We proposed there were two
types of HG, namely congenital and acquired.7 Hypogenesis
is considered to be the initial histological finding of
congenital HG at neonatal period. The 4th International
Symposium on Hirschsprung’s disease and related neuro-
cristopathies discussed that diagnosis of HG was difficult
and the presence of HG was questionable.8 However, our(b) Immaturity
(d) Acquired Hypoganglionosis
sease (ADHD) in hematoxylineeosin staining. (A) Normal ganglia
IHS; chronic idiopathic intestinal pseudo-obstruction, CIIP;
oganglionosis. Arrows indicate small ganglion cells. (D) Acquired
Figure 3 Bcl-2 immunostaining for immaturity of ganglia (2-
day-old boy). Mature ganglion cells (blue arrows) show weekly
positive, while immature ganglion cells (red arrows) show
strongly positive in Bcl-2 immunostaining. Glial cells are not
stained. Therefore, this staining is considered to be able to
distinguish mature ganglion cells, immature ganglion cells, and
glial cells.
Table 6 Dietary status of three poor entities.
Survival
rate
Normal diet
in survivors
Normal diet
in all cases
Congenital
HG
70/90 (78%) 42/69 (60%) 42/89 (48%)
CIIP 50/56 (89%) 13/50 (26%) 13/56 (23%)
MMIHS 10/19 (53%) 1/10 (10%) 1/19 (5%)
CIIP Z chronic idiopathic intestinal pseudo-obstruction;
HG Z hypoganglionosis; MMIHS Z megacystis microcolon in-
testinal hypoperistalsis syndrome.
Allied disorders of Hirschsprung’s disease 33study shows that two types of HG do exist and congenital
HG is one of the two main disorders of ADHD in Japan.
The 4th International Symposium on Hirschsprung’s dis-
ease and related neurocristopathies discussed IND and re-
ported as follows8: (1) almost all the participants believe
that IND does exist; (2) some believe in presently defined
diagnostic criteria, whereas others suggest that these
diagnostic criteria are not reliable enough; and (3) some
participants question if IND is a truly separate entity or an
acquired secondary phenomenon related to long-standing
constipation or chronic obstruction. Therefore, we
decided to include IND as one of ADHD.
The concept of chronic intestinal pseudo-obstruction
(CIPO) including myopathy, neuropathy, collagenopathy
(desmosis or fibrosis), and idiopathic.9 Some CIPO patients
are reported to be adult onset.10 However, most myopathyTable 5 Survival rate of allied disorders of Hirschsprung’s
disease.
Abnormal ganglia Survival rate
IG 28/28 (100%)
HG
Congenital HG 70/90 (78%)
Acquired HG 8/8 (100%)
IND 11/11 (100%)
Normal ganglia
MMIHS 10/19 (53%)
SD 27/27 (100%)
IASA 3/3 (100%)
CIIP 50/56 (89%)
CIIP Z chronic idiopathic intestinal pseudo-obstruction;
HG Z hypoganglionosis; IASA Z internal anal sphincter acha-
lasia; IG Z immaturity of ganglia; IND Z intestinal neuronal
dysplasia; MMIHS Z megacystis microcolon intestinal hypoper-
istalsis syndrome; SD Z segmental dilatation.and neuropathy types of CIPO cannot be diagnosed by
conventional HE and AChE staining. Furthermore, abnor-
malities of Cajal cells shown by c-kit immunostaining were
reported in some cases of CIIP.11 Therefore, so far, we
decided to treat CIIP as a disorder that shows recurrent or
persistent functional intestinal obstruction with normal
histology by conventional staining by HE and AchE. Because
the diagnosis of Hirschsprung’s disease is generally ob-
tained by HE and AchE staining in the most institutes of
Japan, the criteria of ADHD are recommended to be based
on the conventional histology so far. MMIHS has been
considered to be the severe form of CIIP. However, MMIHS
can be distinguished from CIIP by clinical
characteristics.12,13
The entity of SD was proposed by Swenson and Rathauser
in 1959.14 The symptoms and signs of SD, especially sigmoid
type of SD, resemble those of Hirschsprung’s disease.
Therefore, SD is included in ADHD in this study.
The entity of IASA has been considered to be synony-
mous of ultrashort-segment aganglionosis, which shows
normal AchE staining but lacks rectoanal reflex.15 This en-
tity was discussed in The 4th International Symposium on
Hirschsprung’s disease and related neurocristopathies and
was reported to exist.8 Therefore, we decided that IASA is
included in ADHD.
The numbers of cases in each disorder are summarized
and compared with Okamoto and Toyosaka’s5 study in Table
2. The distributions of each disorder are similar in these
two studies. The numbers of patients as well as the answer
rates of criteria were very small in acquired HG and IASA.
The rarity of disease is considered to make criteria difficult.
For definitive pathological diagnosis of ADHD, immnu-
nohistochemical staining has been reported to be useful
using neuronal and muscular markers, such as: Bcl-2 for
immature neurons; CD56 for the size of enteric ganglia;
synaptophysin for neuromuscular innervation: S-100 protein
for Schwann cells; c-kit for interstitial cells of Cajal; and
smooth muscle actin for myopathy.16 The diagnosis of IG
was easily obtained in several of our cases using Bcl-2 im-
munostaining (Figure 2).
In conclusion, almost all Japanese cases of ADHD for 10
years were collected in this study. Congenital HG and CIIP
showed relatively high incidence, whereas acquired HG and
IASA were extremely rare. Criteria of each institute were
consisted with clinical signs, symptoms, and conventional
histological examinations including AchE staining. Congen-
ital HG, MMIHS, and CIIP showed poor survival rate. Further
collection of precise data of each case is required to make
guidelines for criteria and treatment strategies for ADHD.
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